10-K/A: 180 Life Sciences Files Amended 10-K to Include XBRL Tagging

180 Life Sciences Corp. files an amendment to its annual report on Form 10-K to include required XBRL tagging for certain disclosures.

Summary

• 180 Life Sciences Corp. filed an Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
• This amendment is solely to include required XBRL tagging under Item 10, specifically restating Part III, Item 10 (Directors, Executive Officers and Corporate Governance), and 11 (Executive Compensation) of Amendment No. 1.
• New certifications of the principal executive officer and principal financial officer are filed as exhibits to this amendment.
• The original Form 10-K was filed on March 31, 2025, and Amendment No. 1 was filed on April 25, 2025.
• As of March 31, 2025, there were 5,185,780 shares of common stock issued and outstanding, including shares issuable upon conversion of Series B Convertible Preferred Stock.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, indicating compliance and adherence to SEC guidelines. The sentiment is neutral to slightly positive due to the company's commitment to transparency and corporate governance.

Positives

• The company has a strong focus on corporate governance, with independent directors comprising key committees.
• The company has implemented a clawback policy to recover erroneously awarded incentive-based compensation from executive officers.
• The company encourages executive officers and directors to conduct purchase or sale transactions under a trading plan established pursuant to Rule 10b5-1 under the Exchange Act.

Negatives

• Mr. Jordan was Interim CEO, CFO, and a director of Ascent, when on March 1, 2019, the Supreme Court of British Columbia issued an order granting Ascents application for creditor protection under the Companies Creditors Arrangement Act (Canada) ( CCAA ).
• Mr. Jordan was also a director of Mjardin Group Inc., a diversified cannabis company from May 26, 2021 to March 22, 2022. PwC, as receiver, determined to place Mjardin Group Inc. into receivership on March 23, 2022.
• Mr. Smith served as Emerald Oil Inc.s Chief Financial Officer from September 2014 to January 2017. Emerald Oil Inc. filed for Chapter 11 bankruptcy protection in March 2016 and emerged from bankruptcy in November 2016.

Risks

• The division of the Board of Directors into two classes with staggered two-year terms may delay or prevent a change of our management or a change in control.
• The company's insider trading policy prohibits executive officers, directors, and employees from engaging in transactions involving derivative securities, such as put and call options, and short sales, that could generate profit from a decline in the Company’s stock price.

Future Outlook

The document does not contain specific forward-looking statements beyond the standard disclosures.

Management Comments

• Blair Jordan, Chief Executive Officer, certified that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
• Eric R. Van Lent, Chief Accounting Officer, certified that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Industry Context

This filing is a routine amendment to comply with SEC regulations regarding XBRL tagging, which is a standard practice for public companies to improve the accessibility and comparability of financial information.

Comparison to Industry Standards

• The company's corporate governance structure, with independent directors and key committees, aligns with industry best practices.
• The clawback policy is in line with the requirements of the Sarbanes-Oxley Act and SEC rules, similar to policies adopted by other publicly listed companies.
• The company's insider trading policy and anti-hedging provisions are consistent with industry standards to prevent insider trading and ensure compliance with securities laws.

Management Changes

Corporate Governance

Stakeholder Impact

• The filing ensures that stakeholders have access to accurate and comparable financial information.
• The company's commitment to corporate governance and ethical conduct enhances stakeholder confidence.

Key Dates

Keywords

XBRL, directors, executive officers, corporate governance, Form 10-K, 180 Life Sciences, financial reporting, SEC, Amendment